Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Lung Cancer

Free Subscription Articles published in Hum Pathol Retrieve available abstracts of 20 articles: HTML format

Single Articles

February 2024
1. IVANOVA M, Frascarelli C, Cerbelli B, Pignataro MG, et al
   PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores.
   Hum Pathol. 2024;144:22-27.
   PubMed     Abstract available
   
   
   December 2023
2. WANG H, Yan L, Zhu Y, Sun W, et al
   Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas.
   Hum Pathol. 2023;142:81-89.
   PubMed     Abstract available
   
   
   November 2023
3. VAN PEL DM, Cheung S, Ionescu DN, Churg A, et al
   Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.
   Hum Pathol. 2023;141:64-68.
   PubMed     Abstract available
   
   
   August 2023
4. ZHU Y, Li S, Wang H, Chi K, et al
   Molecular subtype expression and genomic profiling differ between surgically resected pure and combined small cell lung cancer.
   Hum Pathol. 2023 Aug 14:S0046-8177(23)00166.
   PubMed     Abstract available
   
   
   May 2023
5. WANG M, Chen PP, Cai G
   GATA3 expression in primary lung carcinomas: correlation with histopathologic features and TTF-1, napsin A, and p40 expression.
   Hum Pathol. 2023;135:93-98.
   PubMed     Abstract available
   
   
   October 2022
6. BOSSE Y, Gagne A, Althakfi W, Orain M, et al
   Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
   Hum Pathol. 2022;128:56-68.
   PubMed     Abstract available
   
   
   
7. ZAFAR R, Schrader LJ, Cheville JC, Schoolmeester JK, et al
   A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
   Hum Pathol. 2022;128:31-47.
   PubMed     Abstract available
   
   
   August 2022
8. CHANG WC, Yeh YC, Ho HL, Chou TY, et al
   Deep exploration of immune function in EGFR wild-type and mutated lung adenocarcinomas by gene expression profiling: role of TRAIL-R2 (TNFRSF10B) in patient treatment and outcome.
   Hum Pathol. 2022;126:9-18.
   PubMed     Abstract available
   
   
   May 2022
9. AMBROSINI-SPALTRO A, Farnedi A, Calistri D, Rengucci C, et al
   The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies' integration.
   Hum Pathol. 2022;123:20-30.
   PubMed     Abstract available
   
   
   April 2022
10. LIU L, Wei J, Teng F, Zhu Y, et al
    Corrigendum to Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery [Hum Pathol 108 (2021) 84-92].
    Hum Pathol. 2022;125:1.
    PubMed    
    
    
    
11. ISHIKAWA R, Kadota K, Ikeda T, Yoshida C, et al
    Prognostic Impact of Tumor-infiltrating Lymphocytes and Neutrophils in Resected Non-small Cell Lung Carcinoma.
    Hum Pathol. 2022 Apr 25. pii: S0046-8177(22)00102.
    PubMed     Abstract available
    
    
    March 2022
12. ZHANG L, Zhang L, Wang XI, Katz G, et al
    The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Hum Pathol. 2022 Mar 21. pii: S0046-8177(22)00070.
    PubMed     Abstract available
    
    
    February 2022
13. MOAYED-ALAEI L, Vargas AC, Adybeik D, Maclean F, et al
    Analyzing the morphological spectrum of epithelioid fibrous histiocytoma and the immunohistochemical performance of the ALK D5F3 and ALK1 clones.
    Hum Pathol. 2022;120:46-56.
    PubMed     Abstract available
    
    
    December 2021
14. LAWLOR RT, Mafficini A, Sciammarella C, Cantu C, et al
    Genomic characterization of hepatoid tumors: context matters.
    Hum Pathol. 2021;118:30-41.
    PubMed     Abstract available
    
    
    September 2021
15. WANG M, Abi-Raad R, Baldassarri R, Adeniran AJ, et al
    Expression of insulinoma-associated protein 1 in non-small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors.
    Hum Pathol. 2021;115:104-111.
    PubMed     Abstract available
    
    
    
16. TONNESEN E, Lade-Keller J, Stougaard M
    Frequently used quantitative polymerase chain reaction-based methods overlook potential clinically relevant genetic alterations in epidermal growth factor receptor compared with next-generation sequencing: a retrospective clinical comparison of 1839 l
    Hum Pathol. 2021;115:67-75.
    PubMed     Abstract available
    
    
    
17. CHEN M, Yang J, Lv L, Li Y, et al
    Comprehensive genetic profiling of six pulmonary nuclear protein in testis carcinomas with a novel micropapillary histological subtype in two cases.
    Hum Pathol. 2021;115:56-66.
    PubMed     Abstract available
    
    
    August 2021
18. WANG B, Chen R, Wang C, Guo J, et al
    Identification of novel ALK fusions using DNA/RNA sequencing in immunohistochemistry / RT-PCR discordant NSCLC patients.
    Hum Pathol. 2021;114:90-98.
    PubMed     Abstract available
    
    
    March 2021
19. ITAMI H, Fujii T, Nakai T, Takeda M, et al
    TRAF7 mutations and immunohistochemical study of uterine adenomatoid tumor compared to malignant mesothelioma.
    Hum Pathol. 2021 Mar 2. pii: S0046-8177(21)00032.
    PubMed     Abstract available
    
    
    February 2021
20. YANAGAWA N, Shiono S, Endo M, Ogata SY, et al
    Programmed death ligand 1 protein expression is positively correlated with the solid predominant subtype, high MIB-1 labeling index, and p53 expression and negatively correlated with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Hum Pathol. 2021;108:12-21.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.